CFTC Grants TAIFEX Exemption to Clear Swaps for US Participants

TAIFEX has relied on temporary no-action relief since September 2022. 'Exempt DCO' status gives it a lasting right to clear OTC derivatives for US participants.

To continue reading...


Subscribe to Regulation Asia to gain access to APAC’s leading platform for news, analysis, research and verified data on financial regulation. Select subscribe below to view our subscription packages or you can email us at [email protected] to discuss your options.


Request a Trial

Get in touch today to discuss a trial giving you unrestricted and unlimited access to Regulation Asia for you and/or your team(s) for a limited period. Email us at [email protected]

To Top
Share via
Copy link
Powered by Social Snap